Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients Who Are Unsuitable for Full-Dose Fludarabine-Based Therapy
AuthID
P-00M-KSV
P-00M-KSV